University of California, Davis |
Gerhard Bauer |
Creativity Awards |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$250,064 |
City of Hope, Beckman Research Institute |
Paul Salvaterra |
Creativity Awards |
Creativity Award Program in Stem Cell Biology for California High School Students |
$260,825 |
Gladstone Institutes, J. David |
Shannon Noonan |
Creativity Awards |
Gladstone Summer Scholars (GSS) internship program |
$35,044 |
University of Southern California |
Roberta Brinton |
Creativity Awards |
CIRM STAR High School Summer Research and Creativity Program |
$271,160 |
University of California, Santa Barbara |
Lina Kim |
Creativity Awards |
Research Mentorship Program-Immersing High School Students in College Research |
$280,726 |
Stanford University |
Paul Utz |
Creativity Awards |
SIMR Program: Stem Cell & Developmental Biology Research Internships |
$340,611 |
UCSF Benioff Children’s Hospital Oakland |
Vasanthy Narayanaswami |
Creativity Awards |
CHORI/UC Berkeley Summer Stem Cell Research Internship Program for High School Students |
$151,046 |
Stanford University |
Thomas Rando |
Conference |
Keystone Symposia, 'The Life of a Stem Cell: From Birth to Death' |
$50,000 |
Buck Institute for Age Research |
Victoria Lunyak |
Conference |
Stem Cell Research and Aging |
$30,000 |
City of Hope, Beckman Research Institute |
Fouad Kandeel |
Conference |
2012 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research |
$15,000 |
International Symposium on Neural Regeneration, Inc. |
Roger Madison |
Conference |
14th International Symposium on Neural Regeneration |
$20,000 |
City of Hope, Beckman Research Institute |
Richard Jove |
Conference |
Innovative Partnerships: Bringing Stem Cell Discoveries to the Clinic |
$14,994 |
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Conference |
Stem Cell Meeting on the Mesa: 6th Annual Scientific Symposium & 1st Annual Investor and Partnering Forum |
$40,000 |
California Institute of Technology |
Paul Patterson |
Conference |
World Stem Cell Summit |
$50,000 |
University of California, Davis |
Alice Tarantal |
Conference |
10th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$18,300 |
OncoMed Pharmaceuticals, Inc. |
Timothy Hoey |
Disease Team Therapy Planning I |
Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency |
$65,120 |
Sanford Burnham Prebys Medical Discovery Institute |
Marcel Daadi |
Disease Team Therapy Planning I |
Neural Stem Cell-Based Therapy For Parkinson’s Disease |
$63,952 |
Cedars-Sinai Medical Center |
Dan Gazit |
Disease Team Therapy Planning I |
Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. |
$107,622 |
University of California, Los Angeles |
Stanley Nelson |
Disease Team Therapy Planning I |
Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$68,947 |
University of California, Davis |
John Laird |
Disease Team Therapy Planning I |
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia |
$76,066 |
University of California, Davis |
Vicki Wheelock |
Disease Team Therapy Planning I |
MSC engineered to produce BDNF for the treatment of Huntington's disease |
$97,564 |
Stanford University |
Judith Shizuru |
Disease Team Therapy Planning I |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$90,147 |
University of California, Davis |
Mehrdad Abedi |
Disease Team Therapy Planning I |
Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$66,880 |
StemCells, Inc. |
Alexandra Capela |
Disease Team Therapy Planning I |
Neuroprotection to treat Alzheimer's: a new paradigm using human central nervous system cells |
$90,101 |
University of California, Los Angeles |
Antoni Ribas |
Disease Team Therapy Planning I |
Genetic Re-programming of Stem Cells to Fight Cancer |
$97,785 |
Stanford University |
Albert Wong |
Disease Team Therapy Planning I |
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma |
$109,750 |
Samumed, LLC |
John Hood |
Disease Team Therapy Planning I |
Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures |
$99,110 |
Sanford Burnham Prebys Medical Discovery Institute |
Stuart Lipton |
Disease Team Therapy Planning I |
hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease |
$96,448 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Disease Team Therapy Planning I |
Stem Cells Secreting GDNF for the Treatment of ALS |
$63,487 |
University of Southern California |
Roberta Brinton |
Disease Team Therapy Planning I |
A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer's Disease |
$107,961 |
Stanford University |
Robert Robbins |
Disease Team Therapy Planning I |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$73,030 |
University of California, Davis |
Nancy Lane |
Disease Team Therapy Planning I |
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis |
$107,750 |
University of California, Davis |
Martin Birchall |
Disease Team Therapy Planning I |
Airways for Children |
$19,800 |
University of California, Los Angeles |
Martina Wiedau-Pazos |
Conference |
California ALS Summit 2011 |
$13,300 |
University of California, San Diego |
Dong-Er Zhang |
Conference |
International RUNX Workshop |
$24,000 |
University of California, Los Angeles |
Adele Rennie |
Patent Assistance Fund Awards |
Patent Assistance Fund - UCLA |
$84,973 |
University of California, Irvine |
Ronnie Hanecak |
Patent Assistance Fund Awards |
CIRM Patent Assistance Fund Application - UCI |
$46,155 |
University of California, Davis |
David McGee |
Patent Assistance Fund Awards |
CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies - UCD |
$48,595 |
University of California, San Francisco |
Karin Immergluck |
Patent Assistance Fund Awards |
Patent Assistance Fund Proposal - UCSF |
$87,257 |
University of California, Santa Barbara |
Bernadette McCafferty |
Patent Assistance Fund Awards |
Intellectual Property in Regenerative Bioengineering from CIRM funded research in regenerative medicine at the University of California, Santa Barbara. |
$23,564 |
Human BioMolecular Research Institute |
John Cashman |
Patent Assistance Fund Awards |
Intellectual Property for Stem Cell-Related Inventions - HBRI |
$50,000 |
University of California, San Diego |
Rubén Flores |
Patent Assistance Fund Awards |
Patent Assistance Fund Application - UCSD |
$38,162 |
Stanford University |
Katharine Ku |
Patent Assistance Fund Awards |
Funding for Patent Applications for CIRM-funded Inventions out of Stanford University |
$3,525 |
Brain Mapping Foundation |
Babak Kateb |
Conference |
8th Annual World Congress for Brain, Spinal Cord Mapping and Image Guided Therapy at Mission Bay Conference Center of UCSF School of Medicine |
$17,200 |
University of California, Los Angeles |
Ali Nsair |
Basic Biology III |
Characterization and Engineering of the Cardiac Stem Cell Niche |
$1,127,741 |
University of California, San Diego |
David Cheresh |
Basic Biology III |
Molecular basis of human ES cell neurovascular differentiation and co-patterning |
$1,359,996 |
University of California, San Diego |
Anirvan Ghosh |
Basic Biology III |
Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells |
$843,597 |
University of California, Los Angeles |
Gay Crooks |
Basic Biology III |
Forming the Hematopoietic Niche from Human Pluripotent Stem Cells |
$1,252,857 |
Stanford University |
Aaron Hsueh |
Basic Biology III |
Correlated time-lapse imaging and single cell molecular analysis of human embryo development |
$1,259,733 |
University of California, Los Angeles |
Kathrin Plath |
Basic Biology III |
Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells |
$1,364,598 |
Stanford University |
Joanna Wysocka |
Basic Biology III |
Enhancer-mediated gene regulation during early human embryonic development |
$1,420,618 |
University of California, San Diego |
Farah Sheikh |
Basic Biology III |
Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC |
$1,341,955 |
University of California, San Diego |
Charles King |
Basic Biology III |
Biological relevance of microRNAs in hESC differentiation to endocrine pancreas |
$1,313,649 |
Stanford University |
Sean Wu |
Basic Biology III |
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells |
$1,260,537 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Basic Biology III |
Mechanisms of Direct Cardiac Reprogramming |
$1,572,380 |
University of California, San Diego |
Binhai Zheng |
Basic Biology III |
Generation and characterization of corticospinal neurons from human embryonic stem cells |
$1,355,063 |
Scripps Research Institute |
Joel Gottesfeld |
Basic Biology III |
Triplet Repeat Instability in Human iPSCs |
$1,705,494 |
University of California, San Francisco |
Jason Pomerantz |
Basic Biology III |
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells |
$1,381,296 |
University of California, Los Angeles |
William Lowry |
Basic Biology III |
Molecular determinants of accurate differentiation from human pluripotent stem cells |
$677,115 |
University of California, Los Angeles |
Yi Sun |
Basic Biology III |
Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo |
$1,382,400 |
University of California, Los Angeles |
Shuo Lin |
Basic Biology III |
Etsrp/ER71 mediated stem cell differentiation into vascular lineage |
$1,378,781 |
Stanford University |
Michael Clarke |
Basic Biology III |
USP16 controls stem cell number: implications for Down Syndrome |
$1,263,826 |
Scripps Research Institute |
Kristin Baldwin |
Basic Biology III |
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing |
$1,705,500 |
University of California, San Diego |
Deborah Spector |
Basic Biology III |
Viral-host interactions affecting neural differentiation of human progenitors |
$1,372,660 |
University of California, San Francisco |
John Murnane |
Basic Biology III |
Genomic instability during culturing of human embryonic stem cells |
$1,070,919 |
University of California, San Diego |
Kun Zhang |
Basic Biology III |
Functional characterization of mutational load in nuclear reprogramming and differentiation |
$1,295,318 |
University of California, Berkeley |
Michael Rape |
Basic Biology III |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,224,805 |
City of Hope, Beckman Research Institute |
Jiing-Kuan Yee |
Basic Biology III |
Use of human iPS cells to study spinal muscular atrophy |
$1,268,868 |
Parkinson's Institute |
R. Jeremy Nichols |
Basic Biology III |
Understanding the role of LRRK2 in iPSC cell models of Parkinson's Disease |
$1,482,822 |
University of California, Berkeley |
Song Li |
Basic Biology III |
Induced Pluripotent Stem Cells for Tissue Regeneration |
$1,209,148 |
University of California, San Diego |
Eugene Yeo |
Basic Biology III |
Neural and general splicing factors control self-renewal, neural survival and differentiation |
$1,287,619 |
University of California, Santa Barbara |
Francis Doyle |
Conference |
12th Annual Systemwide Bioengineering Symposium |
$15,000 |
Cedars-Sinai Medical Center |
John Yu |
Conference |
First Annual Stem Cell Therapies for Neurological Disorders: Overcoming the Current Barriers to Clinical Translation, April 30 (special stem cell program for high school students on April 28) |
$18,500 |
City of Hope, Beckman Research Institute |
Fouad Kandeel |
Conference |
2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research |
$15,000 |
University of California, San Diego |
Lawrence Goldstein |
Tools and Technologies II |
Developing a method for rapid identification of high-quality disease specific hIPSC lines |
$1,686,069 |
Stanford University |
Sarah Heilshorn |
Tools and Technologies II |
Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels |
$600,695 |
GMR Epigenetics |
Jifan Hu |
Tools and Technologies II |
Robust generation of induced pluripotent stem cells by a potent set of engineered factors |
$1,356,052 |
Parkinson's Institute |
Birgitt Schuele |
Tools and Technologies II |
Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases |
$1,327,983 |
University of California, San Francisco |
Daniel Lim |
Tools and Technologies II |
Development and preclinical testing of new devices for cell transplantation to the brain. |
$1,795,891 |
University of California, Los Angeles |
Martin Martin |
Tools and Technologies II |
Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders |
$1,783,250 |
Stanford University |
Brian Rutt |
Tools and Technologies II |
Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters |
$1,833,348 |
University of California, Berkeley |
David Schaffer |
Tools and Technologies II |
Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs |
$1,340,816 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Tools and Technologies II |
Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy. |
$1,933,022 |
Fluidigm Corporation |
Marc Unger |
Tools and Technologies II |
Development and Application of Versatile, Automated, Microfluidic Cell Culture System |
$1,939,236 |
Stanford University |
Michele Calos |
Tools and Technologies II |
Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation |
$1,592,897 |
TriFoil Imaging, Inc. |
Joann Zhang |
Tools and Technologies II |
Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring |
$1,456,989 |
University of California, Los Angeles |
Stanley Carmichael |
Tools and Technologies II |
Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke |
$1,825,613 |
Stanford University |
Irving Weissman |
Tools and Technologies II |
Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs |
$1,463,814 |
University of California, San Diego |
Shu Chien |
Tools and Technologies II |
Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation |
$1,706,628 |
Stanford University |
Marius Wernig |
Tools and Technologies II |
Cellular tools to study brain diseases affecting synaptic transmission |
$1,664,382 |
University of California, Berkeley |
Steven Conolly |
Tools and Technologies II |
Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo |
$1,311,596 |
University of California, San Diego |
Karl Willert |
Tools and Technologies II |
Homologous recombination in human pluripotent stem cells using adeno-associated virus. |
$1,659,043 |
Stanford University |
Theo Palmer |
Tools and Technologies II |
Development of small molecule screens for autism using patient-derived iPS cells |
$1,797,606 |
University of California, Los Angeles |
Richard Gatti |
Tools and Technologies II |
Use of hiPSCs to develop lead compounds for the treatment of genetic diseases |
$1,833,054 |
Gordon Research Conferences |
Catriona Jamieson |
Conference |
2011 Gordon Conference on Stem Cells and Cancer |
$40,000 |
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Conference |
Stem Cell Meeting on Mesa |
$40,000 |
University of California, Los Angeles |
Irvin Chen |
Conference |
Stem Cells: A New Avenue of HIV Research and New Approaches to HIV Treatment |
$24,456 |
University of California, Davis |
Alice Tarantal |
Conference |
9th Annual Gene Therapy Symposium for Heart, Lung and Blood Diseases |
$12,000 |
City of Hope, Beckman Research Institute |
Richard Jove |
Conference |
New Approaches in Cell Based Therapies |
$20,000 |
University of California, Los Angeles |
Bruno Peault |
Early Translational II |
Harnessing native fat-residing stem cells for bone regeneration |
$5,359,076 |